Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit.
Chierakul
Wirongrong
W
Anunnatsiri
Siriluck
S
Chaowagul
Wipada
W
Peacock
Sharon J
SJ
Chetchotisakd
Ploenchan
P
Day
Nicholas P
NP
D002442:Ceftazidime / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007263:Infusions, Parenteral; D008554:Melioidosis / Q000188:drug therapy*; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002442:Ceftazidime